Aerie Pharmaceuticals ROA 2012-2018 | AERI

Current and historical return on assets (ROA) values for Aerie Pharmaceuticals (AERI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Aerie Pharmaceuticals ROA for the three months ending September 30, 2018 was -65.99%.
Aerie Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.24B $0.31B -71.48%
2018-06-30 $-0.19B $0.35B -55.82%
2018-03-31 $-0.16B $0.39B -48.71%
2017-12-31 $-0.15B $0.29B -50.52%
2017-09-30 $-0.12B $0.31B -41.59%
2017-06-30 $-0.11B $0.33B -40.15%
2017-03-31 $-0.10B $0.23B -47.50%
2016-12-31 $-0.10B $0.25B -51.23%
2016-09-30 $-0.09B $0.27B -52.63%
2016-06-30 $-0.08B $0.12B -56.66%
2016-03-31 $-0.08B $0.14B -49.31%
2015-12-31 $-0.07B $0.16B -41.99%
2015-09-30 $-0.07B $0.18B -40.23%
2015-06-30 $-0.07B $0.18B -37.50%
2015-03-31 $-0.06B $0.20B -40.27%
2014-12-31 $-0.05B $0.16B -42.89%
2014-09-30 $-0.04B $0.17B -46.87%
2014-06-30 $-0.04B $0.06B -81.59%
2014-03-31 $-0.04B $0.07B -97.90%
2013-12-31 $-0.03B $0.07B -166.23%
2013-09-30 $-0.02B $0.01B -1200.00%
2013-06-30 $-0.01B $0.00B inf%
2013-03-31 $-0.01B $0.00B -213.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.820B $0.000B
Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's lead `Dual- Action` product and `Triple-Action` products are under developmental stages. Aerie Pharmaceuticals, Inc. is headquartered in Bedminster, New Jersey.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.934B 11.08
Zoetis (ZTS) United States $42.722B 29.25
Grifols (GRFS) Spain $12.967B 15.82
Tilray (TLRY) United States $9.050B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.424B 12.09
Neurocrine Biosciences (NBIX) United States $7.781B 1716.20
Ionis Pharmaceuticals (IONS) United States $7.337B 0.00
Nektar Therapeutics (NKTR) United States $6.345B 9.10
Catalent (CTLT) United States $5.190B 21.77
Impax Laboratories (AMRX) United States $5.043B 26.81
Sage Therapeutics (SAGE) United States $5.043B 0.00
United Therapeutics (UTHR) United States $4.729B 7.73
Loxo Oncology (LOXO) United States $4.145B 0.00
TESARO (TSRO) United States $4.078B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.527B 13.06
FibroGen (FGEN) United States $3.318B 0.00
USANA Health Sciences (USNA) United States $2.882B 24.53
Endo (ENDP) Ireland $2.546B 3.90
Xencor (XNCR) United States $2.110B 0.00
Heron Therapeutics (HRTX) United States $2.101B 0.00
Endocyte (ECYT) United States $1.958B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.904B 257.28
Ironwood Pharmaceuticals (IRWD) United States $1.895B 0.00
Zogenix (ZGNX) United States $1.808B 0.00
PTC Therapeutics (PTCT) United States $1.742B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.738B 0.00
Corcept Therapeutics (CORT) United States $1.499B 22.00
Theravance Biopharma (TBPH) Cayman Islands $1.496B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.457B 20.49
Esperion Therapeutics (ESPR) United States $1.419B 0.00
Portola Pharmaceuticals (PTLA) United States $1.388B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.360B 0.00
Tricida (TCDA) United States $1.338B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.202B 0.00
TherapeuticsMD (TXMD) United States $1.037B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.993B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.807B 0.00
ImmunoGen (IMGN) United States $0.802B 0.00
Radius Health (RDUS) United States $0.726B 0.00
Collegium Pharmaceutical (COLL) United States $0.638B 0.00
Karyopharm Therapeutics (KPTI) United States $0.613B 0.00
Forty Seven (FTSV) United States $0.575B 0.00
Flexion Therapeutics (FLXN) United States $0.543B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.516B 0.00
ChemoCentryx (CCXI) United States $0.507B 40.16
Akebia Therapeutics (AKBA) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.493B 0.00
GlycoMimetics (GLYC) United States $0.463B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.458B 0.00
Dermira (DERM) United States $0.456B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.447B 26.36
Dova Pharmaceuticals (DOVA) United States $0.435B 0.00
Xeris Pharmaceuticals (XERS) United States $0.424B 0.00
Tyme Technologies (TYME) United States $0.407B 0.00
Odonate Therapeutics (ODT) United States $0.406B 0.00
KalVista Pharmaceuticals (KALV) United States $0.405B 0.00
ArQule (ARQL) United States $0.387B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.387B 0.00
Translate Bio (TBIO) United States $0.384B 0.00
CASI Pharmaceuticals (CASI) United States $0.372B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.362B 0.00
Aclaris Therapeutics (ACRS) United States $0.335B 0.00
OptiNose (OPTN) United States $0.330B 0.00
Tapimmune (MRKR) United States $0.327B 0.00
Minerva Neurosciences (NERV) United States $0.309B 0.00
Aratana Therapeutics (PETX) United States $0.307B 0.00
Majesco Entertainment (PTE) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.295B 0.00
Depomed (ASRT) United States $0.272B 10.12
IMV INC (IMV) Canada $0.265B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.262B 0.00
Mast Therapeutics (SVRA) United States $0.260B 0.00
Aldeyra Therapeutics (ALDX) United States $0.245B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.241B 0.00
Ocular Therapeutix (OCUL) United States $0.230B 0.00
Affimed (AFMD) Germany $0.223B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.217B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.212B 0.00
Lannett Co Inc (LCI) United States $0.210B 1.83
Aquestive Therapeutics (AQST) United States $0.207B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.207B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.191B 0.00
Opexa Therapeutics (ACER) United States $0.191B 0.00
Zafgen (ZFGN) United States $0.189B 0.00
Calithera Biosciences (CALA) United States $0.185B 0.00
MEI Pharma (MEIP) United States $0.179B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.172B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 0.00
Recro Pharma (REPH) United States $0.169B 0.00
ContraFect (CFRX) United States $0.164B 0.00
Neon Therapeutics (NTGN) United States $0.161B 0.00
Molecular Templates (MTEM) United States $0.158B 0.00
Ardelyx (ARDX) United States $0.152B 0.00
ElectroCore (ECOR) United States $0.151B 0.00
Redhill Biopharma (RDHL) Israel $0.148B 0.00
MediWound (MDWD) Israel $0.141B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.134B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.133B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.131B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.130B 0.00
Jounce Therapeutics (JNCE) United States $0.127B 0.00
DURECT (DRRX) United States $0.125B 0.00
Cardiome Pharma (CORV) Canada $0.122B 0.00
Adherex Technologies (FENC) United States $0.122B 0.00
ProNAi Therapeutics (SRRA) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
Iterum Therapeutics (ITRM) Ireland $0.108B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
Immune Design (IMDZ) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.097B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.096B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.088B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.087B 0.00
Melinta Therapeutics (MLNT) United States $0.087B 0.00
CTI BioPharma (CTIC) United States $0.086B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.078B 7.70
Entasis Therapeutics Holdings (ETTX) United States $0.078B 0.00
Achaogen (AKAO) United States $0.077B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Infinity Pharmaceuticals (INFI) United States $0.072B 0.00
KemPharm (KMPH) United States $0.071B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.063B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 38.00
Ampio Pharmaceuticals (AMPE) United States $0.057B 0.00
Avenue Therapeutics (ATXI) United States $0.053B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.050B 0.00
Genocea Biosciences (GNCA) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Mannatechorporated (MTEX) United States $0.048B 0.00
Capnia (SLNO) United States $0.039B 0.00
ProPhase Labs (PRPH) United States $0.036B 4.03
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Novan (NOVN) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
Lipocine (LPCN) United States $0.031B 0.00
Trillium Therapeutics (TRIL) Canada $0.030B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
IsoRay (ISR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Biomerica (BMRA) United States $0.022B 0.00
HANCOCK JAFFE (HJLI) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Aviragen Therapeutics (VXRT) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.019B 6.95
Pain Therapeutics (PTIE) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Shineco (TYHT) China $0.014B 1.58
Regulus Therapeutics (RGLS) United States $0.013B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Aradigm (ARDM) United States $0.009B 0.00
Skyline Medical (AIPT) United States $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00